← All trials
NCT01912716
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2013
- Primary completion
- Jul 1, 2017
- Completion date
- Jul 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 1036
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Indiana UniversityLead sponsor
- Indiana UniversityOverall official - principal investigator
- University of MichiganCollaborator
- University of WisconsinCollaborator
- American College of GastroenterologyCollaborator
- Medical University of South CarolinaCollaborator
- Indiana UniversityReponsible party - principal investigator
- The University of Texas, DallasCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.